New York Times: The Baby Formula Crisis
Is my baby getting enough food? It is a typical fear among new parents — and an acute one now, because of a national shortage of baby formula.
A potential bacteria outbreak led to the February shutdown of a Michigan factory that makes Similac formula, and the plant still has not reopened. Its closure has aggravated shortages created by broader pandemic supply-chain problems. Last week, stores stocked about 43 percent less baby formula than usual.
…
2. Big business
The baby formula business has something in common with many other U.S. industries: It is highly concentrated.
Three companies — Abbott, Gerber and Reckitt — make nearly all of the formula that Americans use. Abbott is the largest of the three, with roughly 40 percent of the market.
Over the past few decades, this kind of corporate concentration has become more common in the U.S. economy, and it tends to be very good for companies. They face less competition, allowing them to keep prices higher and wages lower. Thomas Philippon, an economist at N.Y.U., refers to this trend as “the great reversal.” The subtitle of his 2019 book on the subject is “How America Gave Up on Free Markets.”
For workers and consumers, concentration is often problematic. The baby-formula shortage is the latest example. If the market had more producers, a problem at any one of them might not be such a big deal. It’s even possible the problem would not happen at all.
“Abbott does not fear consumers will flee,” Sarah Miller, executive director of the American Economic Liberties Project, which advocates less concentration, told me. “And it does not fear government, which has a pathetic track record when it comes to holding powerful corporations and executives accountable.” (The Times has profiled Miller and her work.)